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Behçet’s disease (BD) is a chronic, relapsing, multi-system inflammatory disorder
of unknown aetiology with complicated and diversified clinical features of
mucocutaneous lesions and ocular, vascular, articular, gastrointestinal, urogential,
pulmonary and neurological involvement.
1-5 The pathogenesis of BD is probably
mediated by a combination of factors involving genetic factors, immune factors,
environmental factors and infectious agents.
6 The disease exhibits a distinct
geographic variation. It is particularly prevalent along the ancient “Silk Road”
countries from Northwest China to the Mediterranean basin, although BD has
been reported all over the world. Turkey has the highest incidence of BD in the
world (80-300 per 100,000).
1 In contrast, the prevalence is quite low in USA (1 : 1,
500,000).
7 Some clinical features of this disease have been described to be
different according to the geographical areas.
1,2 The pathergy reaction is
considered to be highly sensitive and specific for BD in patients from Japan and
Turkey and is rare in patients from Western countries, the frequency of
gastrointestinal involvement is much lower in the Mediterranean than that in Far
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Purpose: Behçet’s disease (BD) is a chronic, relapsing, multi-system vasculitis of unknown aetiology with
complicated and diversified clinical features predominantly involving oral and genital ulcers, and ocular and
cutaneous lesions. The clinical features of this disease have been described to be different according to
geographical areas and gender. We investigated the specific clinical features of BD patients in Northeastern China.
Materials and Methods: 116 patients involved in this study fulfilled the classification criteria of the International
Study Group for BD. The clinical manifestations and results of laboratory tests of BD were recorded in each
patient. Results: The onset was typically between 20-39 years with a slight female predominance. Oral ulcers were
the most common manifestation, followed by skin lesions, positive pathergy reaction/genital ulcers, and ocular
lesions. Vascular lesion and epididymitis were rare in patients with BD. The frequency of erythema nodosum-like
lesion and articular involvement were significantly higher in females, while gastrointestinal involvement was
significantly higher in males. The results of laboratory tests showed that the human leukocyte antigen (HLA)-B*51
alleles were positive in 30.9% of patients and the immunological abnormities were present in some patients.
Conclusion: The clinical features of BD showed geographical and gender difference. Genetic and immune factors
might participate in aetiopathogenesis of BD.
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INTRODUCTIONEast, ocular involvement is more severe in Japanese patients
compared with that in patients from the United Kingdom.
Moreover, regional differences in the prevalence of the
disease within a country have been reported from Korea
and Japan.
8,9 The clinical feature of BD also shows a
gender difference.
10-12 Male preponderance has been
reported in the Middle Eastern countries, but women are
more commonly affected in Japan and Korea.
2,12 Eye
disease, arthritis, folliculitis and vascular involvement are
more common among males, while erythema nodosum
were more frequent in females
11,12 The mean age at the
onset of patients with the worst prognosis is younger in
males.
12 Because of the lack of a universally recognized
pathognomonic laboratory test, the diagnosis of BD is
mainly based on the characteristic clinical features and
criteria plus the judgment of experienced physicians through
mucocutaneous manifestations. In 1990, the International
Study Group for BD proposed the criteria for the diagnosis
that have been accepted and used worldwide.
13
We aimed to investigate the specific clinical features of
BD patients in Northeastern China so as to make sure
whether there are gender differences in clinical features of
BD and try to identify the effects of various factors, such
as genetic, and immune factors in aetiopathogenesis of
BD. China is one of East Asian countries, near Korea and
Japan. We also compared the results with those of various
areas in China, Korea and Japan in the literature in order to
find out geographical differences in clinical features of BD.
Subjects
Total 116 patients with BD (52 male, 64 female) who
attended the Department of Dermatology, No.1 Hospital of
China Medical University in Shenyang, China and Depart-
ment of Dermatology, No.1 Affiliated Hospital of Dalian
Medical University in Dalian, China between 2002 and
2006, fulfilled the classification criteria of the International
Study Group for BD
13 and were involved in the study. The
presence, absence and characteristics of each clinical mani-
festation were evaluated by specialists of related symptoms
such as ophthalmologist for ocular lesion, and rheumatolo-
gist for articular involvement. The pathergy reaction was
performed using a 20-gauge needle which was intrader-
mally introduced obliquely on the flexor forearm under
sterile conditions and read 24-48 h later by a physician.The
appearance of a papule or pustule was considered to be a
positive reaction.
Laboratory tests
Laboratory tests of all the patient with BD were carried out
in the Clinical Laboratory, and Immunology Laboratory of
Department of Dermatology, No.1 Hospital of China Medi-
cal University, and included blood and urine routine exa-
mination, erythrocyte sedimentation rate (ESR), serum
immunoglobulin (Ig)G, IgA, IgM, C3, C4, antinuclear
antibody (ANA), anti-double stranded DNA (ds DNA)
antibody and anti-extractable nuclear antigen (ENA)
antibodies. In addition, HLA-B typing in 68 patients was
performed by LABType
TM SSO method in Liaoning
Province Blood Center. One hundred ethnically and
regionally matched, unrelated healthy voluntary blood
donors served as controls. 
Statistical analysis
The t test was used to analyze the continuous variables.
The chi-square test was used to analyze the categorical
variables. Differences were defined as statistically signifi-
cant at p < 0.05. All data were assessed on computer using
a SPSS 12.0 software package.
Clinical manifestations
All 116 patients with BD (52 male, 64 female: male to
female ratio of 0.81) were 5-60 years of disease onset
(mean ± SD age 28.0 ± 12.4 years) with no significant
difference (p > 0.05) between male (26.5 ± 13.1 years) and
female patients (29.2 ± 12.0 years). There were 32 patients
with disease onset at below 20 years, 67 patients at 20-39
years, 15 patients at 40-59 years and 2 patient over 60
years. There were no significant differences (p > 0.05)
between male (6.1 ± 5.3 years) and female patients (6.4 ±
7.8 years) among BD patients with the duration of 0.25-30
years (6.2 ± 6.3 years).  
The clinical findings in 116 patients with BD are shown
in Table 1. Oral ulcers were seen in all 116 patients with
BD during the clinical course and were the initial symptom
of the disease in 100 patients (86.2%). Oral ulcers often
appeared in buccal mucosa, gingivae, tongue, lips and soft
palate. Ninety four (81.0%) of 116 patients with BD had
cutaneous lesions, mainly manifesting as pseudofollicullitis
or papulopustular lesions, erythema nodosum-like lesions
and erythema multiforme-like lesions, whereas a minority
as ecchymosis, blister, ulcer, psoriasisform lesions and
sweet disease-like lesions. Female patients with nodosum-
like lesions were significantly higher than males (p < 0.05).
Eighty two (70.7%) of 116 patients with BD had positive
skin pathergy reaction. Of 116 patients, 82 patient (70.7%)
were found to have genital ulcers. Genital ulcers were the
initial manifestation of 10 patients (9.5%) with BD, com-
monly seen in scrotum, penis and glans in male and labia,
The Clinical Feature of Behçet’s Disease in Northeastern China
Yonsei Med J   http://www.eymj.org    Volume 50   Number 5   October 2009 631
MATERIALS AND METHODS
RESULTSvagina and cervix uteri in female. Fifty four (46.6%) of
116 patients with BD had ocular lesions, including posterior
uveitis such as retinal vasculitis, vitritis, optic neuritis and
anterior uveitis, including iridocyclitis, hypopyon, conjunc-
tivitis, keratitis, and scleritis.
Involvement of the joint occurred in 51 patients (44.0%),
manifesting asymmetric arthritis. The most common site
was knees, followed by the ankles, elbows, wrists and coxa.
Joint involvement was more frequent in females than in
males (p <0.05). Twenty two patients with gastrointestinal
involvement had the symptoms of abdominal pain, disten-
sion, discomfort, diarrhea, constipation, and hematochezia.
Eight male patients among them were found with gastric/
duodenal ulcer, revealed by gastroscopy, and 1 female
patients with colonic ulcer was confirmed by colonoscopy.
Gastrointestinal involvement was more frequent in males
than in females (p < 0.05). Of 116 patients, only 1 patient
(0.9%) suffered from epididymitis, complaining of swell-
ing and pain. Five patients (4.3%) were found to have
vascular lesion, occurring in lower limbs as superficial
thrombophlebitis. Twenty nine patients (25.0%) were
found with neurological involvement, and most of them
with feeled headache and dizzy. Only two patients had
severe symptoms: one with psychiatric symptoms and the
other with unstable walk and trouble in speaking, and
magnetic resonance imaging showed brain atrophy. Forty
two patients (36.2%) with urogential involvement manife-
sted asymptomatic proteinuria and/or simple hematuria.
Two case (1.7%) were found with cardiac involvement, and
both of them felt recurrent precordial distress and electrocar-
diogram showed myocardial ischemia. In addition, 22
patients (19.0%) with fever, 22 patients (19.0%) with hypo-
dynamia, and 9 patients (7.8%) with myalgia were included. 
Moreover, we found that 15 patients (12.9%: 8 male, 7
female) had family history of recurrent oral ulcer in their
first-degree relatives, in which 4 (3.4%) were confirmed
BD cases.
Laboratory examinations
Peripheral blood WBC in 25 of 116 patients (21.6%) was
increased, and 18 patients (15.5%) showed increased urine
protein ranging from trace (150 mg/24 h) to 2+, and increas-
ed urine protein was more frequent in males than in females
(p < 0.05). Twenty five patients (21.6%) had increased
urinary red blood cell (RBC), 51 patients (44.0%) increas-
ed ESR, 22 cases (19.0%) IgG type, 22 cases (19.0%) IgA
type, and 14 cases (12.1%) IgM type. Increased IgM was
more frequent in females than in males (p < 0.05). C3 was
decreased in 14 cases (12.1%), while C4 in 12 cases
(10.3%). Decreased C3 and C4 were more frequent in
females than in males (p < 0.05, respectively). The positive
rates of ANA, anti-dsDNA, and anti-ENA were 6.9%,
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Table 1.The Clinical Manifestations in 116 Patients with BD
Clinical manifestations
Number of patients (%)
Total (n = 116) Male (n = 52) Female (n = 64)
Oral ulceration 116 (100.0%) 52 (100.0%) 64 (100.0%)
Genital ulceration 82 (70.7%) 41 (78.8%) 41 (64.1%)
Ocular lesion 54 (46.6%) 23 (44.2%) 31 (48.4%)
Pseudofollicullitis or papulopustular lesions 65 (56.0%) 30 (57.7%) 35 (54.7%)
Erythema nodosum-like lesions 45 (38.8%) 12 (20.7%)* 33 (51.6%)
Pseudofollicullitis or papulopustular 
22 (19.0%) 7 (13.5%) 15 (23.4%)
lesions and erythema nodosum-like lesions
Positive skin pathergy reaction  82 (70.7%) 39 (75.0%) 43 (67.2%)
Articular involvement 51 (44.0%) 14 (26.9%)* 37 (57.8%)
Gastrointestinal involvement 22 (19.0%) 17 (32.7%)* 5 (7.8%)
Epididymitis 1 (0.9%) 1 (1.9%) 0 (0.0%)
Vascular lesion 5 (4.3%) 3 (5.8%) 2 (3.1%)
Neurological involvement 29 (25.0%) 14 (26.9%) 15 (23.4%)
Urogential involvement 42 (36.2%) 22 (42.3%) 20 (31.3%)
Cardiac involvement 2 (1.7%) 0 (0.0%) 2 (3.1%)
Fever 22 (19.0%) 13 (25.0%) 9 (14.1%)
Hypodynamia 22 (19.0%) 11 (21.2%) 11 (17.2%)
Myalgia 9 (7.8%) 4 (7.7%) 5 (7.8%)
BD, Behçet’s disease.
*p< 0.05 indicated that male patients were significantly different from female patients.14.7% and 10.3%, respectively (Table 2).
Total 68 patients and 100 controls were studied for
HLA-B alleles, in which 21 patients (30.9%) and 12
controls (12%) had positive HLA-B*51 alleles. The gene
frequency of HLA-B*51 was significantly higher in BD
patients than those in controls (p < 0.05). The frequency
of HLA-B*51 alleles in male and female patients was
35.1% and 25.8%, respectively, indicating no gender
difference (p > 0.05).
In this study, we evaluated clinical features of BD patients
in Northeastern China, and also compared the results with
those of various areas in China, Korea, and Japan. The
comparative data of clinical features of BD are presented
in Table 3.
14-18 It suggested that there were certain differences
in clinical features of BD among different regions in East
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Table 2.The Results of Laboratory Examinations
Laboratory examinations
Number of patients (%)
Total (n = 116) Male (n = 52) Female (n = 64)
Increased blood WBC 25 (21.6%) 15 (28.8%) 10 (15.6%)
Increased urine protein 18 (15.5%) 16 (30.8%)
� 2 (3.1%)
Increased urine RBC 25 (21.6%) 7 (13.5%) 18 (28.1%)
Increased ESR 51 (44.0%) 22 (42.3%) 29 (45.3%)
Elevated IgG 22 (19.0%) 8 (15.4%) 14 (21.9%)
Elevated IgA 22 (19.0%) 10 (19.2%) 12 (18.8%)
Elevated IgM 14 (12.1%) 0 (0.0%)* 14 (21.9%)
Decreased C3 14 (12.1%) 2 (3.8%)* 12 (18.7%)
Decreased C4 12 (10.3%) 0 (0.0%)* 12 (18.7%)
ANA positive 8 (6.9%) 2 (3.8%) 6 (9.4%)
Anti-dsDNA positive 17 (14.7%) 7 (13.5%) 10 (15.6%)
Anti-ENA positive 12 (10.3%) 3 (5.8%) 9 (14.1%)
WBC, white blood cell; RBC, red blood cell; ESR, erythrecyte sedimentation rate, Ig, immunoglobulin, ANA, antinuclear antibody; ds-DNA, 
double stranded DNA; ENA, extractable nuclear antigen.
*p< 0.05, 
�p< 0.01 indicated that male patients were significantly different from female patients.
Table 3.Clinical Features in Different Regions of East Asia
China
Clinical features Korea
14 Japan
15 Guang
Northeast
dong
16  Hubei
17 Beijing
18 The current 
study
No. of patients 3,497 3,316 60 58 84 116
Mean age at onset (yr) 33.0 - - - - 28.0
Male to female ratio 0.57 - 2.3 0.61 1.65 0.81
Oral ulcers (%) 98.8 98 96.7 94.8 100 100
Genital ulcers (%) 83.2 73 71.7 70.7 88.1 70.7
Ocular lesion (%) 50.9 69 51.7 36.2 40.5 46.6
Pseudofollicullitis or 84.3* 87* 33.3 26.6 17.9 56.0
Papulopustular lesions (%)
Erythema nodosum-like lesions (%) 48.3 63.8 27.4 38.8
Positive skin pathergy reaction (%) 15.4 44 68.3 53.5 62.3 70.7
Articular involvement (%) 38.4 57 43.3 34.5 71.4 44.0
Gastrointestinal involvement (%) 7.3 16 6.7 8.6 23.8 19.0
Neurological involvement (%) 4.6 11 8.3 0 10.7 25.0
Epididymitis %) 0.6 6 - - - 1
Vascular lesion (%) 1.8 9 11.7 5.2 14.3 4.3
*described as skin lesions.
DISCUSSIONAsia.
In our study, recurrent oral ulceration was the most
common basic symptom, followed by skin lesions, genital
ulceration/positive skin pathergy reaction, and ocular
lesion. Oral ulcerations were found in 100% of patients,
indicating key bases of diagnosing BD. Genital ulceration
was less significant, compared with oral ulceration. Solitary
genital ulceration hardly suggested BD, and diagnosis
could not easily be made based on genital ulceration, and
similar diseases should be ruled out. Pseudofollicullitis and
papulopustular lesions were frequent occurrence in skin
lesions, followed by erythema nodosum-like lesions.
These results differed from those in other parts of China,
16-18
however, similar with the report from Turkey.
19 It was quite
common for ocular lesion to be a slight symptom. Since
only 6 patients with ocular involvement were severe: 3
cases with iridocyclitis, one case with hypopyon, iridocy-
clitis, lens opacity and vitreous opacity, one case with
vitreous opacity, and corneal macula, and another one with
secondary complications of cataract and maculopathy.
Five above-mentioned cases were treated timely with
corticosteroids and didn’t lose their eyesight during follow-
up. Pathergy, the occurrence of a pustular lesion 24 hours
after cutaneous trauma, has been found to be useful as a
diagnostic marker in some studies. In 1990, the Internatio-
nal Study Group Criteria were published to include a
positive pathergy test as one of the criteria to establish the
diagnosis of BD. It is thought to denote increased neutrophi
chemotaxis with an infiltration of polymorphonuclear
leukocytes (PMNLs) first followed by mononuclear and
mast cells.
20 It is also related with disease activity and
systemic involvement. Although positive pathergy reaction
occurs much more commonly in Turkish and German,
19,21
it only occurs in about 15% of Korean patients,
14 and 44%
of Japanese patients,
15 reducing its diagnostic value in
these groups. In our study we found pathergy in 82 of 116
patients with BD, and it also showed a high incidence in
other regions of China,
16-18 suggesting that it has a diagno-
stic value and is specific to BD in China.
The major pathologic process of BD is vasculitis chara-
cterized by multisystemic involvement. Our results showed
that articular, urogential, neurological and gastrointestinal
involvements were common, however, the prevalence of
epididymitis, vascualr and cardic involvement was low.
Pulmonary involvement was not found. As many as 44.0%
of patients with BD had arthritis. The knees and ankles
were most commonly involved, although smaller joints
also were affected in a few patients. The arthritis was typi-
cally oligoarticular in the majority of patients. No patients
experienced destructive, deforming arthritis of small joints.
Spondyloarthristides was not seen. Renal vasculitis was
characterized by diffuse or focal glomerular abnormalities.
Although renal involvement was common in the present
study, most patients with renal involvement had slight
symptoms and showed mild proteinuria and microscopic
hematuria with normal renal function, consistent with
previous report.
22 Gastrointestinal involvement in BD is
characterized by ulceration along the gastrointestinal tract,
and we found 8 patients with gastric/duodenal ulcer, 1
patient with colonic ulcer, and other patients with functional
abnormalities. Most neurological manifestations of this
group of patients included headaches and dizzy without
specificity. Only 2 cases showed serious symptoms, and
brain stem involvement was not seen. Epididymitis and
vascular involvements were also rare: only one patient
suffered from epididymitis, similar to reports from Korea,
14
and 5 patients were found to have superficial thromboph-
lebiti. Further follow-up will be required to investigate whe-
ther other vascular involvement experiences longer time.  
The diagnosis of BD has been based on clinical criteria
and no pathognomonic laboratory fingdings. Several
laboratory tests have been studied, but none has been
found to be specific for BD. Abnormal values such as
leukocytosis, increased erythrocyte sedimentation rate, and
elevated IgG, IgA, and IgM are often seen in disease
exacerbations. In our study, the presence of elevated IgG,
IgA, and IgM, and decreased C3, C4 and some autoantibody
such as ANA, anti-dsDNA and anti-ENA indicated that
immunological mechanisms might play a major part in
aetiopathogenesis of BD. HLA-B*51, the genetic marker
of BD, has been reported to exhibit strong association with
the disease in different ethnic groups.
23 The frequency of
HLA-B*51 in patients with BD was 25-80%.
24-28 HLA-
B*51 in the present study was positive in 30.9% of BD
patients, while the frequency of HLA-B*51 alleles in con-
trols was only 12%. On the other hand, familial recurrent
oral ulcer was described in 12.9% of patients with BD.
These results suggested that genetic factor might be
associated with BD. The difference in the frequency of
HLA-B*51 between our study and literatures indicated
that the association between HLA-B*51 and BD had
ethnic and geographic differences. Our findings suggested
that both genetic and environmental factors might contri-
bute to the occurrence and development of the disease.
The clinical features of BD are different according to the
gender.
10-12 In the present study, female patients were
slightly more than males, however, there were no differen-
ces in mean age of disease onset and mean duration between
male and female patients. These results differed from
previous observation on a lower age of BD onset in men.
29
As for clinical findings, female patients with nodosum-like
lesions were significantly higher than males. The difference
in oral ulcers, genital ulcers, ocular lesion, and positive
skin pathergy reaction between male and female patients
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in women were usually deeper and larger than those in
men, while 6 patients with serious ocular involvement
were all men. The strong reaction of skin pathergy such as
pustule formation was significantly more common in male
patients. There was no difference in other manifestations
between male and female patients, apart from joint invol-
vement which was more common in women, and gastroin-
testinal involvement which was more common in men.
Eight patients with gastric/duodenal ulcer were all male,
while only one female patient with colonic ulcer was found.
Laboratory test showed that more male patients than
female ones were positive for increased urine protein, but
female patients were more than male ones for elevated
IgM and decreased C3, and C4. Although positive HLA-
B*51 was encountered more commonly in male patients in
the current study, there was no statistical significance.
With regard to the treatment of this group of patients,
tripterygium wilfordii, compound Glycyrrhizin, and transfer
factor were effective for mucococutaneous manifestation.
Systemic corticosteroids and/or immunosuppressive agents,
including azathioprine, methotrexate, cyclophosphamide,
cyclosporin, and immunomodulators including interferon,
were used when eye, brain, kidney and gastrointestinal
tract were severely involved and genital ulcerations were
large, deep and severely painful. Non-steroidal anti-inflam-
matory drugs were also an effective alterative treatment for
joint involvement and erythema nodosum-like lesion. At
the same time, topical therapy was administered. These
treatments seemed to be variably effective without obvious
side-effects during follow-up.
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